Skip to content

Can oral medication replace Insulin Injections in pregnant women with Diabetes

A Randomized open label trial of efficacy& safety of Metformin versus subcutaneous insulin in Asian Indian women with Gestational diabetes?

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/08/001956
Enrollment
120
Registered
2011-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Gestational Diabetes

Interventions

Intervention1: Metformin: Tab Metformin 500mg orally three times a day upto 2500mg/day duration will be untill delivery. Control Intervention1: None: N/A Control Intervention2: Insulin Therapy: Subcut

Sponsors

ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ?Receiving prenatal care at Department of Obstetrics and Gynaecology AIIMS New Delhi ?In the second trimester of pregnancy ?Singleton or twin pregnancy ?Able to give informed consent ?No history of Bad obstetric history (Previous two or more abortions, still births and neonatal deaths) ?No History of congenital anomalies in previous babies

Exclusion criteria

Exclusion criteria: ?End organ complications of diabetes (retinopathy renal insufficiency etc) ?Prior adverse reaction (i e lactic acidosis) or allergy to Metformin ?liver disease ?Significant medical co-morbidities (lupus cystic fibrosis etc) Hypertension controlled on one medication well controlled asthma and well controlled thyroid diseases are not excluded. ?Bad obstetric history (Previous two or more abortions still births and neonatal deaths) ?History of congenital anomalies in previous babies

Design outcomes

Primary

MeasureTime frame
Effect and efficacy of Metformin on pregnancy and Achieving defined glycemic targets and comparing it with InsulinTimepoint: N/A

Secondary

MeasureTime frame
Need for additional Insulin in achieving the glycemic targets Pregnancy complications in both the groups (Hydramnios, Macrosomia,Congenital malformations) Acceptability and satisfaction of treatment (Satisfaction score chart) Neonatal complications (Hypoglycaemia, Hyper-bilirubinemia, NICU admission Timepoint: N/A

Countries

India

Contacts

Public ContactDr Neeta Singh

All India Institute of Medical Sciences. (AIIMS)

drneetasingh@yahoo.com26594251

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026